Overview

InduPro focuses on targeted cancer and autoimmune disease therapies by mapping how proteins sit on the surface of cells. Its ProXiMATE discovery engine uses proximity labeling and deep learning to chart protein neighborhoods and identify disease-enriched protein pairs, guiding the design of bispecific antibodies and antibody-drug conjugates. The ARRIS platform applies multi-specific antibodies to co-localize two surface proteins under a tumor-associated proximity antigen approach to improve selectivity. The company aims to advance its first therapeutic candidate toward IND filing by late 2025 and seeks partnerships to accelerate development.